Last week →  The rescheduling record is closed — briefs due Aug 17

Congress finally has a bill to stop the hemp ban. The White House isn't sold.

For months the November 12 hemp recriminalization has loomed with no realistic vehicle to stop it. That changed on July 22: Reps. Andy Barr (R-KY) and Angie Craig (D-MN) filed the Lawful Hemp Protection Act, a 60-page framework that would replace the scheduled 0.4 mg-per-container standard with a 1% total-THC definition of hemp, plus federal registration, labeling, taxes, and potency caps — 5 mg per serving for oral products and 50 mg for inhalables if HHS fails to set its own. Then the story got complicated. Barr's office says the White House supports the bill; an administration official declined to endorse it, and sources say the sticking point is inhalable products. The alcohol lobby's wholesaler arm backs it — with reservations about the tax rate — and hemp lawyers note THCA flower is left outside its protections. A vehicle exists. Whether it moves before November is the question that matters.

Why it matters: This is the first filed bill built specifically to replace the November 12 recriminalization rather than repeal it as a rider. The 1% total-THC standard would preserve most of the edible and beverage market; the default potency caps would reshape SKUs; and the reported White House objection to inhalables signals vapes may be traded away in negotiation. Analyses also flag THCA flower as unprotected. Plan inventory against the current deadline until something is enacted.

Barr and Craig filed the 60-page bill July 22. It sets hemp at 1% total THC dry weight, adds federal registration, labeling and excise taxes, and defaults to 5 mg/serving oral, 50 mg/serving inhalable and 50 mg/serving topical caps if HHS doesn't set limits. Barr's release claims White House support; an administration official declined to endorse it, and the Wine & Spirits Wholesalers backed it while calling the tax rate unsettled.

Why it matters: The official who signed April's interim Schedule III order is now hedging on the full rule — in writing. With post-hearing briefs due August 17 and no deadline after that, the administrator's discretion is the whole game, and the person likely to hold it just declined to show his hand. Budget planning should continue to treat §280E relief as unbooked until a final rule survives review. Talk to your counsel before changing tax positions.

In written answers to Sen. Alex Padilla following his July 15–16 confirmation hearings, Acting AG Todd Blanche declined to say whether he supports moving all cannabis to Schedule III or reducing penalties, writing he would give the matter "careful consideration" after conferring with DEA personnel. His nomination remains uncertain, with at least two Judiciary Committee Republicans undecided.

Why it matters: Cannabis operators mostly buy thin coverage at surplus-lines prices because carriers fear federal exposure. An insurance-specific safe harbor — narrower than SAFE Banking, and therefore possibly easier to pass — would widen the carrier pool and pressure premiums. Nothing changes until enacted, but operators renewing policies this year should ask brokers how admitted-market entry would reprice their program.

Sens. Kevin Cramer (R-ND) and Ruben Gallego (D-AZ) filed a bill July 22 barring federal regulators from penalizing insurance companies solely for covering state-legal cannabis businesses and their landlords and service providers.

Why it matters: Ohio's experience shows these suits can win partial relief — an injunction covering only the plaintiffs — which splits the market rather than freezing the law. Virginia operators should not bank on a court save: the August 15 cap remains the operative deadline for SKU audits, labels, and sell-through plans. Brands selling into Virginia from out of state have the strongest interest in watching who the plaintiffs are.

Virginia hemp businesses told Richmond BizSense on July 22 they intend to seek a court injunction against the state's new hemp restrictions, including the 2 mg total-THC-per-package cap effective August 15. The CCA opened a violation tip line earlier this month; details of the suit are still emerging.

Why it matters: Rule changes that arrive as red-line edits are easy to miss and easy to violate. Registered organizations, dispensing facilities, and certifying practitioners in New York should run the Part 113 changes against current SOPs now rather than discovering the deltas in an inspection. Compliance officers: this is a documented-review week.

OCM's amendments to the Part 113 medical cannabis regulations took effect this week; the agency published the final red/green edit text showing changed operational requirements.

Why it matters: Federal rescheduling does not reschedule anything at the state level — each state's controlled substances schedule moves on its own. Alabama's hearing is an early test of whether conservative states mirror the federal move or hold their lines; the answer shapes criminal exposure and product rules in every restrictive state where hemp-derived products circulate.

The Alabama State Committee of Public Health held a July 22 hearing on rescheduling marijuana under state law in line with the federal interim Schedule III order, taking testimony that included opposition from conservative advocacy groups. No decision was announced.

Why it matters: Microbial recalls keep landing across mature markets, and aspergillus is the recurring culprit. Cultivators should treat post-harvest handling and remediation validation as audit-ready records; retailers should confirm recall SOPs can isolate affected batches within hours, not days. Regulator data audits increasingly find these problems before complaints do.

Arizona regulators announced a recall of two marijuana products over possible aspergillus contamination, urging consumers to check batch information.

Why it matters: Most jurisdictions legalize first and discover the banking problem later; the federation is sequencing it the other way. For Caribbean medical cannabis ventures — and the correspondent banks that serve the region — a purpose-built framework could become the template small jurisdictions copy, and a quiet competitive edge in attracting licensed operators.

The government of Saint Kitts and Nevis engaged a regional expert to develop a banking framework for its medicinal cannabis industry, aiming to give licensed businesses access to formal financial services from launch.

A light week abroad — fuller international coverage resumes as material lands.

The Barr–Craig bill is now Path 2 in the race against November 12 — but it's one of several. Our explainer maps every realistic route to averting the hemp recriminalization, from CAOA to appropriations riders, with an operator planning matrix by product THC content. Read the summary →